# FORUM MARKETS Inc: financial statements, quarterly

FRMM · Nasdaq · CIK 1690080 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frmm.md) · [Financials](/companies/frmm/financials.md) · [Filings](/companies/frmm/filings.md) · [Insiders](/companies/frmm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frmm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [4.1](/filings/0001213900-25-111023.md) | [2.4 d](/filings/0001213900-26-037888.md) | [2.9](/filings/0001213900-26-057817.md) | [1.4](/filings/0001213900-26-090100.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.0](/filings/0001213900-26-090100.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.4](/filings/0001213900-26-090100.md) |
| Research and development | $m | [1.0](/filings/0001213900-24-098508.md) | [(0.0) d](/filings/0001213900-25-026273.md) | [0.4](/filings/0001213900-25-044259.md) | [0.1](/filings/0001213900-25-066984.md) | [0.3](/filings/0001213900-24-098508.md) | [0.3 d](/filings/0001213900-25-026273.md) | [0.2](/filings/0001213900-25-044259.md) | [0.2](/filings/0001213900-25-066984.md) | not reported | not reported | not reported | not reported |
| Operating income | $m | [(3.5)](/filings/0001213900-24-098508.md) | [(1.5) d](/filings/0001213900-25-026273.md) | [(2.1)](/filings/0001213900-25-044259.md) | [(1.8)](/filings/0001213900-25-066984.md) | [(0.6)](/filings/0001213900-25-111023.md) | [(0.9) d](/filings/0001213900-26-037888.md) | [(2.0)](/filings/0001213900-26-057817.md) | [(1.4)](/filings/0001213900-26-090100.md) | [(220)](/filings/0001213900-25-111023.md) | [(9.6) d](/filings/0001213900-26-037888.md) | [(4.6)](/filings/0001213900-26-057817.md) | [(9.9)](/filings/0001213900-26-090100.md) |
| Interest expense | $m | [0.0](/filings/0001213900-23-085300.md) | [0.0 d](/filings/0001213900-24-025262.md) | [0.0](/filings/0001213900-24-043746.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.0](/filings/0001213900-26-057817.md) | [0.2](/filings/0001213900-26-090100.md) |
| Income tax | $m | [(2.3)](/filings/0001213900-24-098508.md) | [(0.0) d](/filings/0001213900-25-026273.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(10.3)](/filings/0001213900-24-098508.md) | [(1.2) d](/filings/0001213900-25-026273.md) | [(1.1)](/filings/0001213900-25-111023.md) | [0.0](/filings/0001213900-25-111023.md) | [(0.8)](/filings/0001213900-25-111023.md) | [(12.3) d](/filings/0001213900-26-037888.md) | [(2.4)](/filings/0001213900-26-090100.md) | [(1.7)](/filings/0001213900-26-090100.md) | [(217)](/filings/0001213900-25-111023.md) | [(230) d](/filings/0001213900-26-037888.md) | [(76.3)](/filings/0001213900-26-090100.md) | [(12.8)](/filings/0001213900-26-090100.md) |
| Diluted EPS | $ per share | [(24.53)](/filings/0001213900-24-098508.md) | not reported | [(1.68)](/filings/0001213900-25-044259.md) | [0.01](/filings/0001213900-25-066984.md) | [(5.43)](/filings/0001213900-25-111023.md) | not reported | [(5.54)](/filings/0001213900-26-057817.md) | [(2.36)](/filings/0001213900-26-090100.md) | [(16.80)](/filings/0001213900-25-111023.md) | not reported | [(3.64)](/filings/0001213900-26-057817.md) | [(0.73)](/filings/0001213900-26-090100.md) |
| Basic EPS | $ per share | [(24.53)](/filings/0001213900-24-098508.md) | not reported | [(1.68)](/filings/0001213900-25-044259.md) | [0.01](/filings/0001213900-25-066984.md) | [(5.43)](/filings/0001213900-25-111023.md) | not reported | [(5.54)](/filings/0001213900-26-057817.md) | [(2.36)](/filings/0001213900-26-090100.md) | [(16.80)](/filings/0001213900-25-111023.md) | not reported | [(3.64)](/filings/0001213900-26-057817.md) | [(0.73)](/filings/0001213900-26-090100.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-09-04) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.0](/filings/0001213900-25-026273.md) | not reported | [1.1](/filings/0001213900-24-067741.md) | [0.2](/filings/0001213900-24-098508.md) | [4.6](/filings/0001213900-25-111023.md) | [3.7](/filings/0001213900-25-044259.md) | [2.2](/filings/0001213900-25-066984.md) | [1.4](/filings/0001213900-25-111023.md) | [53.3](/filings/0001213900-25-111023.md) | [8.0](/filings/0001213900-26-090100.md) | [65.9](/filings/0001213900-26-057817.md) | [4.1](/filings/0001213900-26-090100.md) |
| Current assets | $m | [3.6](/filings/0001213900-25-026273.md) | [1.9](/filings/0001213900-24-043746.md) | [2.3](/filings/0001213900-24-067741.md) | [1.2](/filings/0001213900-24-098508.md) | [5.1](/filings/0001213900-26-037888.md) | [4.0](/filings/0001213900-25-044259.md) | [3.1](/filings/0001213900-25-066984.md) | not reported | [562](/filings/0001213900-25-111023.md) | [13.6](/filings/0001213900-26-090100.md) | [82.5](/filings/0001213900-26-057817.md) | [14.2](/filings/0001213900-26-090100.md) |
| Total assets | $m | [5.3](/filings/0001213900-25-026273.md) | [3.4](/filings/0001213900-24-043746.md) | [3.9](/filings/0001213900-24-067741.md) | [10.5](/filings/0001213900-24-098508.md) | [12.8](/filings/0001213900-26-037888.md) | [11.7](/filings/0001213900-25-044259.md) | [10.7](/filings/0001213900-25-066984.md) | not reported | [1,009](/filings/0001213900-25-111023.md) | [306](/filings/0001213900-26-090100.md) | [208](/filings/0001213900-26-057817.md) | [159](/filings/0001213900-26-090100.md) |
| Current liabilities | $m | [5.1](/filings/0001213900-25-026273.md) | [4.1](/filings/0001213900-24-043746.md) | [4.0](/filings/0001213900-24-067741.md) | [6.4](/filings/0001213900-24-098508.md) | [3.5](/filings/0001213900-26-037888.md) | [3.9](/filings/0001213900-25-044259.md) | [5.3](/filings/0001213900-25-066984.md) | not reported | [55.8](/filings/0001213900-25-111023.md) | [40.9](/filings/0001213900-26-090100.md) | [13.3](/filings/0001213900-26-057817.md) | [5.3](/filings/0001213900-26-090100.md) |
| Total liabilities | $m | [5.4](/filings/0001213900-25-026273.md) | [4.4](/filings/0001213900-24-043746.md) | [4.3](/filings/0001213900-24-067741.md) | [6.7](/filings/0001213900-24-098508.md) | [3.5](/filings/0001213900-26-037888.md) | [3.9](/filings/0001213900-25-044259.md) | [5.3](/filings/0001213900-25-066984.md) | not reported | [564](/filings/0001213900-25-111023.md) | [66.9](/filings/0001213900-26-090100.md) | [39.3](/filings/0001213900-26-057817.md) | [31.2](/filings/0001213900-26-090100.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [14.3](/filings/0001213900-26-090100.md) |
| Current portion of debt | $m | [0.0](/filings/0001213900-25-026273.md) | not reported | not reported | not reported | [0.0](/filings/0001213900-25-026273.md) | not reported | not reported | not reported | not reported | not reported | not reported | [2.9](/filings/0001213900-26-090100.md) |
| Shareholders' equity | $m | [(0.1)](/filings/0001213900-26-037888.md) | [(1.0)](/filings/0001213900-25-111023.md) | [(0.4)](/filings/0001213900-25-111023.md) | [3.7](/filings/0001213900-25-111023.md) | [9.3](/filings/0001213900-26-090100.md) | [7.7](/filings/0001213900-26-090100.md) | [5.4](/filings/0001213900-26-090100.md) | not reported | [445](/filings/0001213900-25-111023.md) | [239](/filings/0001213900-26-090100.md) | [168](/filings/0001213900-26-090100.md) | [128](/filings/0001213900-26-090100.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.8) d](/filings/0001213900-24-098508.md) | [(2.2) d](/filings/0001213900-25-026273.md) | [(1.0)](/filings/0001213900-25-044259.md) | [0.7 d](/filings/0001213900-25-066984.md) | [(0.2) d](/filings/0001213900-25-111023.md) | [(0.6) d](/filings/0001213900-26-037888.md) | [(0.9)](/filings/0001213900-26-057817.md) | [(1.5) d](/filings/0001213900-26-090100.md) | [(16.0) d](/filings/0001213900-25-111023.md) | [(7.6) d](/filings/0001213900-26-037888.md) | [(20.5)](/filings/0001213900-26-057817.md) | [(12.4) d](/filings/0001213900-26-090100.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.8 d](/filings/0001213900-26-037888.md) | [16.8](/filings/0001213900-26-057817.md) | [0.0 d](/filings/0001213900-26-090100.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [30.1 d](/filings/0001213900-26-037888.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2.0](/filings/0001213900-23-085300.md) | [0.2](/filings/0001213900-24-043746.md) | [0.3](/filings/0001213900-24-067741.md) | [0.4](/filings/0001213900-24-098508.md) | [0.6](/filings/0001213900-25-044259.md) | [0.9](/filings/0001213900-25-066984.md) | [0.1](/filings/0001213900-25-111023.md) | [0.4](/filings/0001213900-26-057817.md) | [0.6](/filings/0001213900-26-090100.md) | [12.4](/filings/0001213900-25-111023.md) | [21.3](/filings/0001213900-26-057817.md) | [17.1](/filings/0001213900-26-090100.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,198,948 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-090100.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.